P387 The addition of an immunosuppressant is an effective optimization strategy after loss of response to anti-TNF-alpha monotherapy in patients with inflammatory bowel disease: a two-year experience
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.